Washington—Fecal microbiota transplant is an effective treatment for symptoms of irritable bowel syndrome with predominant abdominal bloating, according to results of a double-blind trial.
Nearly half of the patients treated with FMT reached the primary end point of adequate symptom relief 12 weeks after treatment versus 29% of those treated with placebo. In addition, FMT patients had statistically significant reductions from baseline in discomfort, number of stools, urgency, flatulence